Industry overview of Curaleaf, CV Sciences, Elixinol, and Green Thumb Industries CBD product lines (Feb 2019)
Summary
The passage provides a market‑focused summary of several publicly traded cannabis/MSO companies and their product expansions. It contains no specific allegations, financial flows, or connections to hi Curaleaf launched a CBD line sold in 47 states, targeting pharmacy chains and grocery stores. Curaleaf reported ~$45 M revenue for FY9M18 with 247% YoY growth and 57% gross margin. CV Sciences’ PlusC
This document is from the House Oversight Committee Releases.
View Source CollectionPersons Referenced (1)
Tags
Related Documents (6)
Industry overview of cannabis and hemp companies with revenue and partnership details
The passage provides commercial financial metrics and partnership information for several cannabis‑related firms. It contains no references to high‑ranking officials, government agencies, or illicit a GTI reports $41.7 M revenue with >300% YoY growth. Khiron Life Sciences entered a 50/50 JV with U.S. Dixie Brands for Latin American CBD cosmetics. Level Brands acquired CBD consumer brand cbdMD, gen
Global Cannabis Regulation and Banking Restrictions Highlight International Legal Frictions
The passage outlines general challenges in cross‑border cannabis trade and banking due to UN drug conventions and U.S. AML rules. It mentions banks and countries but provides no specific names, transa Canadian firms are cultivating cannabis in South America for export. U.S. banks have threatened to cut ties with Uruguayan banks serving legal cannabis pharmacies. International drug treaties (1961,
Ackrell Capital Report Highlights Funding Gap and Investor Activity in Cannabis Industry
The passage provides market analysis and investment trends in the cannabis sector but lacks specific allegations, names of high‑profile officials, or actionable misconduct leads. It mentions corporate Cannabis companies raised over $2 billion in 2017, mostly from retail and family‑office investors. Strategic investors such as Constellation Brands and Scotts Miracle‑Gro have made notable investment
Cannabis market pricing trends and banking challenges highlighted in House Oversight report
The passage provides market analysis and banking data for the cannabis industry, mentioning California State Treasurer John Chiang and FinCEN SAR filings. While it offers useful statistics for financi State‑legal cannabis prices are higher than illegal market prices, but price parity is approaching a Large‑scale cannabis cultivation is expected in Colombia and Uruguay for export to Canada and Germ
Industry benchmarking report on publicly traded CBD companies
The passage provides market sizing and retail footprint data for cannabis‑derived companies but contains no specific allegations, financial flows, or links to high‑level officials. It offers limited i Lists CEOs and executives of several CBD firms (e.g., Brian Athaide of TGOD, James Hamilton of NEPT) Notes an agreement between Organigram and 1812 Hemp for hemp research. Provides retail store count
Cannabis company acquisitions and licensing activity in Uruguay (2018‑2019)
The passage lists corporate transactions and licensing details for cannabis firms operating in Uruguay. While it provides concrete company names and dates, it does not implicate high‑ranking political Aurora acquired Uruguay‑based ICC Labs Inc. in 2018, gaining a GMP‑certified lab and CBD brand BIDIO Khiron purchased NettaGrowth International Inc. in Jan 2019, obtaining one of Uruguay’s two medica
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.